跳至主要内容
临床试验/NCT03817541
NCT03817541Unknown不适用

Expiratory and Plasma Propofol Concentration in Bariatric and Cholecystectomy Patients

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年11月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
2
主要终点
exhaled propofol concentration

研究概览

简要总结

Determination of accuracy With Edmond (reg) expiratory propofol measurement Device, compared With concommitant plasma samples of propofol

详细描述

Edmon (trade mark) is a New Device from BBraun, measuring the expiratory concentration of propofol in anaesthetized patients.

The investigators will test the accuracy and stability of such measurements in comparison With plasma propofol Levels.

The investigators will test during target Control infusion (Marsh model) and assumed stable plasma Levels.

Plasma samples of propofol will be taken for comparison With exhaled propofol.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients admitted to Oslo University Hospital, scheduled for elective laparoscopic bariatric surgery or elective laparoscopic cholecystectomy.
  • Both genders.
  • Age 18-60 years, both inclusive.
  • BMI ≥ 20 kg/m2, 10 patients with BMI 20-30, and 10 patients with BMI > 40
  • ASA classification I-III

排除标准

  • • Known hypersensitivity or other contraindication to propofol administered as Target Controlled Infusion.
  • Patients which during a preoperative visit are deemed not to tolerate propofol bolus or infusion as administered by Target Controlled Infusion.
  • Ongoing neuroleptic medication.

研究组 & 干预措施

Bariatric surgery

Experimental

Patients due for bariatric surgery, BMI > 30

干预措施: Edmon (reg), BBraun (Device)

Cholecystectomy

Experimental

Normal weight patients due for cholecystectomies

干预措施: Edmon (reg), BBraun (Device)

结局指标

主要结局

exhaled propofol concentration

时间窗: start of anaesthesia to end of anaesthesia, 2-3 hours in total

parts per billion

propofol plasma concentration

时间窗: 4-6 samples in the period between start and end of anaesthesia

microg pr ml

次要结局

  • calculated plasma concentration(From start of anaesthesia until end of anaesthesia, 1-3 hrs in total)
  • BIS(from start of anaesthesia until end of anaestheisa, 1-3 hours in total)
  • calculated effect site concentration(from start of anaesthesia until end of anaesthesia, 1-3 hours in total)
  • EEG Power spectrum(f)
  • EEG Power distribution(from start of anaesthesia until end of anaesthesia, 1-3 hours in total)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Johan C Ræder

Professor

Oslo University Hospital

研究点 (2)

Loading locations...

相似试验